Therefore, it could be suggested that lncRNA mediated regulation of Akt signalling seems to highly important in determining the sensitivity of NSCLC cells to EGFR TKI, such as gefitinib. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.